1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Fertility Services Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Cause of Infertility
5.5 Market Breakup by Procedure
5.6 Market Breakup by Service
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Cause of Infertility
6.1 Male Infertility
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Female Infertility
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Procedure
7.1 In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Surrogacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Intrauterine Insemination (IUI)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Service
8.1 Fresh Non-Donor
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Frozen Non-Donor
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Egg and Embryo Banking
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Fresh Donor
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Frozen Donor
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by End-User
9.1 Fertility Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Surgical Centres
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Clinical Research Institutes
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Cryobanks
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by Region
10.1 Europe
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 North America
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Instituto Bernabéu Group
15.3.2 INVO Bioscience, Inc.
15.3.3 Monash IVF Group
15.3.4 Apollo Hospitals Enterprise Ltd.
15.3.5 CARE Fertility Group Ltd.
15.3.6 Carolinas Fertility Institute
15.3.7 Genea Limited
15.3.8 The Cooper Companies, Inc.
15.3.9 Virtus Health Group
15.3.10 Vitrolife Sweden AB
15.3.11 The Johns Hopkins Health System Corporation
15.3.12 Medicover AB (publ)
15.3.13 OvaScience, Inc.
15.3.14 Progyny, Inc.
15.3.15 Xytex Corporation